Molecular Glues Market Size to Hit USD 11.59 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Molecular Glues Market

5.1. COVID-19 Landscape: Molecular Glues Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Molecular Glues Market, By Type

8.1. Molecular Glues Market Revenue and Volume Forecast, by Type

8.1.1. Monovalent Molecular Glues (Classic glues like IMiDs)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Bivalent/Multispecific Glues (Next-gen rational designs)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. CELMoDs™ (Cereblon E3 Ligase Modulating Drugs)

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Molecular Glues Market, By Application

9.1. Molecular Glues Market Revenue and Volume Forecast, by Application

9.1.1. Oncology (Solid Tumors, Hematologic Malignancies)

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Neurology (Alzheimer’s, Parkinson’s, Neurodegeneration)

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Immunology & Inflammation (Autoimmune diseases)

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Molecular Glues Market, By Technology/Process

10.1. Molecular Glues Market Revenue and Volume Forecast, by Technology/Process

10.1.1. Phenotypic Screening (Serendipitous discovery)

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Structure-Based Drug Design (SBDD)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. AI/Machine Learning-Enabled Discovery

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. High-Throughput Screening (HTS)

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Molecular Glues Market, By End-User

11.1. Molecular Glues Market Revenue and Volume Forecast, by End-User

11.1.1. Pharmaceutical & Biotechnology Companies

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Academic & Research Institutes

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Contract Research Organizations (CROs)

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Molecular Glues Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Type

12.1.2. Market Revenue and Volume Forecast, by Application

12.1.3. Market Revenue and Volume Forecast, by Technology/Process

12.1.4. Market Revenue and Volume Forecast, by End-User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Type

12.1.5.2. Market Revenue and Volume Forecast, by Application

12.1.5.3. Market Revenue and Volume Forecast, by Technology/Process

12.1.5.4. Market Revenue and Volume Forecast, by End-User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Type

12.1.6.2. Market Revenue and Volume Forecast, by Application

12.1.6.3. Market Revenue and Volume Forecast, by Technology/Process

12.1.6.4. Market Revenue and Volume Forecast, by End-User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Type

12.2.2. Market Revenue and Volume Forecast, by Application

12.2.3. Market Revenue and Volume Forecast, by Technology/Process

12.2.4. Market Revenue and Volume Forecast, by End-User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Type

12.2.5.2. Market Revenue and Volume Forecast, by Application

12.2.5.3. Market Revenue and Volume Forecast, by Technology/Process

12.2.5.4. Market Revenue and Volume Forecast, by End-User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Type

12.2.6.2. Market Revenue and Volume Forecast, by Application

12.2.6.3. Market Revenue and Volume Forecast, by Technology/Process

12.2.6.4. Market Revenue and Volume Forecast, by End-User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Type

12.2.7.2. Market Revenue and Volume Forecast, by Application

12.2.7.3. Market Revenue and Volume Forecast, by Technology/Process

12.2.7.4. Market Revenue and Volume Forecast, by End-User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Type

12.2.8.2. Market Revenue and Volume Forecast, by Application

12.2.8.3. Market Revenue and Volume Forecast, by Technology/Process

12.2.8.4. Market Revenue and Volume Forecast, by End-User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Type

12.3.2. Market Revenue and Volume Forecast, by Application

12.3.3. Market Revenue and Volume Forecast, by Technology/Process

12.3.4. Market Revenue and Volume Forecast, by End-User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Type

12.3.5.2. Market Revenue and Volume Forecast, by Application

12.3.5.3. Market Revenue and Volume Forecast, by Technology/Process

12.3.5.4. Market Revenue and Volume Forecast, by End-User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Type

12.3.6.2. Market Revenue and Volume Forecast, by Application

12.3.6.3. Market Revenue and Volume Forecast, by Technology/Process

12.3.6.4. Market Revenue and Volume Forecast, by End-User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Type

12.3.7.2. Market Revenue and Volume Forecast, by Application

12.3.7.3. Market Revenue and Volume Forecast, by Technology/Process

12.3.7.4. Market Revenue and Volume Forecast, by End-User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Type

12.3.8.2. Market Revenue and Volume Forecast, by Application

12.3.8.3. Market Revenue and Volume Forecast, by Technology/Process

12.3.8.4. Market Revenue and Volume Forecast, by End-User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Type

12.4.2. Market Revenue and Volume Forecast, by Application

12.4.3. Market Revenue and Volume Forecast, by Technology/Process

12.4.4. Market Revenue and Volume Forecast, by End-User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Type

12.4.5.2. Market Revenue and Volume Forecast, by Application

12.4.5.3. Market Revenue and Volume Forecast, by Technology/Process

12.4.5.4. Market Revenue and Volume Forecast, by End-User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Type

12.4.6.2. Market Revenue and Volume Forecast, by Application

12.4.6.3. Market Revenue and Volume Forecast, by Technology/Process

12.4.6.4. Market Revenue and Volume Forecast, by End-User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Type

12.4.7.2. Market Revenue and Volume Forecast, by Application

12.4.7.3. Market Revenue and Volume Forecast, by Technology/Process

12.4.7.4. Market Revenue and Volume Forecast, by End-User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Type

12.4.8.2. Market Revenue and Volume Forecast, by Application

12.4.8.3. Market Revenue and Volume Forecast, by Technology/Process

12.4.8.4. Market Revenue and Volume Forecast, by End-User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Type

12.5.2. Market Revenue and Volume Forecast, by Application

12.5.3. Market Revenue and Volume Forecast, by Technology/Process

12.5.4. Market Revenue and Volume Forecast, by End-User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Type

12.5.5.2. Market Revenue and Volume Forecast, by Application

12.5.5.3. Market Revenue and Volume Forecast, by Technology/Process

12.5.5.4. Market Revenue and Volume Forecast, by End-User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Type

12.5.6.2. Market Revenue and Volume Forecast, by Application

12.5.6.3. Market Revenue and Volume Forecast, by Technology/Process

12.5.6.4. Market Revenue and Volume Forecast, by End-User

Chapter 13. Company Profiles

13.1. Bristol Myers Squibb (BMS)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerTypeance

13.1.4. Recent Initiatives

13.2. Novartis AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerTypeance

13.2.4. Recent Initiatives

13.3. Monte Rosa Therapeutics

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerTypeance

13.3.4. Recent Initiatives

13.4. C4 Therapeutics, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerTypeance

13.4.4. Recent Initiatives

13.5. Evotec SE

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerTypeance

13.5.4. Recent Initiatives

13.6. Proxygen GmbH

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerTypeance

13.6.4. Recent Initiatives

13.7. Seed Therapeutics

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerTypeance

13.7.4. Recent Initiatives

13.8. Pfizer Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerTypeance

13.8.4. Recent Initiatives

13.9. Roche (Genentech)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerTypeance

13.9.4. Recent Initiatives

13.10. Eli Lilly and Company

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerTypeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The molecular glues market size is expected to increase from USD 2.65 billion in 2025 to USD 11.59 billion by 2035.

Answer : The molecular glues market is expected to grow at a compound annual growth rate (CAGR) of around 15.90% from 2026 to 2035.

Answer : The major players in the molecular glues market include Bristol Myers Squibb (BMS), Novartis AG, Monte Rosa Therapeutics, C4 Therapeutics, Inc., Evotec SE, Proxygen GmbH, Seed Therapeutics, Pfizer Inc., Roche (Genentech), Eli Lilly and Company, Nurix Therapeutics, Neomorph, Inc., Kymera Therapeutics, and Arvinas, Inc.

Answer : The driving factors of the molecular glues market are the increasing R&D in targeted protein degradation and rapid advancements in structural biology.

Answer : North America region will lead the global molecular glues market during the forecast period 2026 to 2035.